logo-loader
NASDAQ:CYCC

Cyclacel Pharmaceuticals Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$6.36 m
Price
0.37 USD
Change
1.70%
52 weeks high
1.02
52 weeks low
0.28

In brief

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases.